H
Hande Turna
Researcher at Istanbul University
Publications - 62
Citations - 6180
Hande Turna is an academic researcher from Istanbul University. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 15, co-authored 57 publications receiving 4334 citations.
Papers
More filters
Journal ArticleDOI
Prognostic significance of CD44 and c-erb-B2 protein overexpression in patients with gastric cancer.
TL;DR: It was showed that there was no correlation between c-erb-B2 positivity and OS, except for CD44, and significant association of simultaneous positivities of c- Derbyshire B2 and CD44 with OS of patients with gastric cancer.
Journal ArticleDOI
GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients.
Nir Peled,Roni Gillis,Saadettin Kilickap,Patrizia Froesch,Sergei V. Orlov,E. Filippova,Umut Demirci,Petros Christopoulos,Irfan Cicin,Fatma Buğdaycı Başal,Cengiz Yilmaz,Moiseenko Fedor,Taner Korkmaz,Semra Paydas,Oliver Gautschi,Alisan Zirtiloglu,Yesim Eralp,Havva Yesil Cinkir,Ahmet Sezer,Mustafa Erman,Deniz Tural,Hande Turna,Julien Mazieres,Elizabeth Dudnik,Noemi Reguart,D.R. Camidge,Terry L. Ng,Filiz Çay Şenler,Ismail Beypinar,Doğan Yazılıtaş,Ahmet Demirkazik,Aziz Karaoglu,Kerem Okutur,Hasan Şenol Coşkun,Mehmet Ali Nahit Sendur,Abdurrahman Isikdogan,Devrim Cabuk,Perran Fulden Yumuk,Ibrahim Yildiz,Mehmet Ali Kaplan,Ozgur Ozyilkan,Ilhan Oztop,Ömer Fatih Ölmez,Kübra Aydın,Adnan Aydiner,Nezih Meydan,R. Grinberg,Laila C. Roisman +47 more
TL;DR: Lorlatinib shows outstanding EC/IC efficacy in ALK/ROS1(+) NSCLC and is supported by previous reports, while mOS from of 90 ± 24 months is unprecedented for ROS1(+NSCLC).
Journal ArticleDOI
Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center
TL;DR: The clinical, pathologic and prognostic characteristics of gastroenteropancreatic neuroendocrine tumors from a single center from Turkey were analyzed and compared with the current medical literature.
Journal Article
Relation of serum vascular endothelial growth factor as an angiogenesis biomarker with nitric oxide & urokinase-type plasminogen activator in breast cancer patients.
TL;DR: It is demonstrated that the angiogenic activity was increased in patients with breast cancer and VEGF levels as an angiogenesis marker may be associated with uPA.
Journal ArticleDOI
Paraneoplastic pemphigus associated with fludarabine use.
Ozcan Yildiz,Mustafa Ozguroglu,M. Teoman Yanmaz,Hande Turna,Sabiha Gokcen Kursunoglu,Meltem Antonov,Server Serdaroğlu,Cuyan Demirkesen,Evin Buyukunal +8 more
TL;DR: The temporal association between fludarabine use and paraneoplastic pemphigus suggests there is an etiopathological link between these two entities.